Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 3
2019 3
2020 1
2021 1
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
MiRNA-146a-A Key Player in Immunity and Diseases.
Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E, Bakhtiyarova K, Gilyazova G, Gupta S, Khusnutdinova E, Gupta H, Pavlov V. Gilyazova I, et al. Among authors: bakhtiyarova k. Int J Mol Sci. 2023 Aug 14;24(16):12767. doi: 10.3390/ijms241612767. Int J Mol Sci. 2023. PMID: 37628949 Free PMC article. Review.
[The role of glutamate in the pathogenesis of multiple sclerosis].
Kuzmina US, Zainullina LF, Vakhitov VA, Bakhtiyarova KZ, Vakhitova YV. Kuzmina US, et al. Among authors: bakhtiyarova kz. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(8):160-167. doi: 10.17116/jnevro2019119081160. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31626185 Review. Russian.
[Primary progressive multiple sclerosis: current issues of timely diagnosis].
Popova EV, Boyko AN, Barabanova MA, Antipova LN, Bakhtiyarova KZ, Belova AN, Solovieva VS, Belskaya GN, Lukashevich IG, Nikolaeva LI, Volkova LI, Turova EL, Kraeva AV, Goncharova ZA, Malkova NA, Poverennova IE, Sivertseva SA, Zhelnin AV, Trushnikova TN, Khabirov FA, Khaibullin TI. Popova EV, et al. Among authors: bakhtiyarova kz. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):35-40. doi: 10.17116/jnevro201711710235-40. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 29359731 Review. Russian.
[Clinical cases of multiple sclerosis in children with cerebral palsy].
Sivertseva SA, Bykova OV, Bakhtiyarova KZ, Prilenskaya AM, Sivertsev MY, Kandala NS, Bazhukhin DV, Smirnova NF, Guseva ME, Boyko AN. Sivertseva SA, et al. Among authors: bakhtiyarova kz. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):55-61. doi: 10.17116/jnevro201811808255. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 30160669 Russian.
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent.
Rakhimov RR, Sultanbaev AV, Izmailov AA, Menshikov KV, Zabelin VM, Izmailov AA, Gilyazova GR, Izmailova SM, Bakhtiyarova KS, Izmailova AA, Gilyazova IR. Rakhimov RR, et al. Among authors: bakhtiyarova ks. Curr Pharm Des. 2023;29(41):3312-3323. doi: 10.2174/0113816128262498231122072050. Curr Pharm Des. 2023. PMID: 38037838
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].
Khachanova NV, Bakhtiyarova KZ, Boyko AN, Vlasov YV, Davydovskaya MV, Evdoshenko EP, Zakharova MN, Kotov SV, Popova EV, Sivertseva SA, Totolyan NA, Khabirov FA. Khachanova NV, et al. Among authors: bakhtiyarova kz. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(3):82-91. doi: 10.17116/jnevro202012003182. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 32323949 Russian.
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial].
Boyko AN, Boyko OV, Bakhtiyarova KZ, Gusev EI, Dudin VA, Zaslavsky LG, Malkova NA, Parshina YV, Poverennova IY, Siverceva SA, Totolyan NA, Shchur SG, Fedulov AS, Khabirov FA, Bolsun DD, Zinkina-Orikhan AV, Linkova YN, Chernovskaya TV. Boyko AN, et al. Among authors: bakhtiyarova kz. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):62-71. doi: 10.17116/jnevro202212201162. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35175704 Clinical Trial. Russian.
19 results